Peter Schwarz
Overview
Explore the profile of Peter Schwarz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
5922
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ricciardi L, Silvestro O, Martino G, Catalano A, Vicario C, Lund-Jacobsen T, et al.
Front Psychol
. 2024 Sep;
15:1394954.
PMID: 39246313
Background: Growing evidence reveals the important role of clinical psychological factors in chronic-immune diseases. The aim of this study was to investigate Health-Related Quality of Life (HR-QoL), depression, anxiety, and...
12.
Rohold C, Jorgensen H, Vojdeman F, Madsen C, Olsen A, Heegaard A, et al.
Acta Diabetol
. 2024 Sep;
62(3):397-404.
PMID: 39227489
Aims: Plasma levels of Vitamin D (25(OH)D) have been suggested as a predictor for developing type 2 diabetes. The purpose of this study was therefore to investigate if a measurement...
13.
Borge S, Sennels H, Schwarz P, Jorgensen H
Scand J Clin Lab Invest
. 2024 Aug;
84(5):305-310.
PMID: 39163206
Purpose: This aim of this study was to assess the possible association between diurnal oscillations and biochemical markers associated with calcium homeostasis. This included the markers parathyroid hormone (PTH), total...
14.
Marina D, Buch-Larsen K, Gillberg L, Andersen M, Andersson M, Rasmussen A, et al.
Cancer Med
. 2024 Aug;
13(15):e70015.
PMID: 39108148
Objective: Adjuvant chemotherapy is often indicated in patients diagnosed with early breast cancer (EBC). Among others, weight gain is one of the observed side effects of both chemotherapy and other...
15.
Jansen R, Buch-Larsen K, Schwarz P
Calcif Tissue Int
. 2024 May;
115(1):99.
PMID: 38806757
No abstract available.
16.
Jenkins A, Ogle G, Scibilia R, Schwarz P, Brennan F
BMJ
. 2024 May;
385:q1109.
PMID: 38760071
No abstract available.
17.
Rejnmark L, Gosmanova E, Khan A, Makita N, Imanishi Y, Takeuchi Y, et al.
Adv Ther
. 2024 May;
41(6):2500-2518.
PMID: 38691316
Introduction: Individuals with chronic hypoparathyroidism managed with conventional therapy (active vitamin D and calcium) have an increased risk for renal dysfunction versus age- and sex-matched controls. Treatments that replace the...
18.
Schnell O, Barnard-Kelly K, Battelino T, Ceriello A, Elding Larsson H, Fernandez-Fernandez B, et al.
Cardiovasc Diabetol
. 2024 Mar;
23(1):104.
PMID: 38504284
The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform for...
19.
Buch-Larsen K, Gillberg L, Ahmed H, Marstrand S, Andersson M, van Hall G, et al.
Nutrition
. 2024 Mar;
122:112394.
PMID: 38458062
Background: Breast cancer survivors are a growing population due to improved treatment. It is known that postmenopausal women treated for breast cancer may experience weight gain and increased insulin resistance,...
20.
Yahyavi S, Holt R, Knudsen N, Andreassen C, Sejling C, Meddis A, et al.
Bone
. 2024 Feb;
182:117053.
PMID: 38395247
Background: Antiresorptive treatment is currently used in millions of patients with osteoporosis and cancer worldwide. Early studies of denosumab suggested a small signal in ovarian cancer incidence and emerging data...